MedPath

A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes

Phase 3
Completed
Conditions
Myelodysplastic Syndromes
Registration Number
NCT00050843
Lead Sponsor
Celgene Corporation
Brief Summary

The primary objective of the study is to determine the efficacy of thalidomide for the treatment of anemia in patients with myelodysplastic syndromes (MDS).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
220
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (38)

Beaumont Cancer Center

🇺🇸

Royal Oak, Michigan, United States

Texas Oncology PA-BMT Center

🇺🇸

Dallas, Texas, United States

Northwest Medical Specialists

🇺🇸

Arlington Heights, Illinois, United States

South Shore Hem-Onc Assoc. PA

🇺🇸

Rockville Centre, New York, United States

Roswell Park Cancer Institute

🇺🇸

Buffalo, New York, United States

Westchester County Medical Center

🇺🇸

Valhalla, New York, United States

Buffalo Medical Group PC

🇺🇸

Williamsville, New York, United States

MCP Hahnemann University

🇺🇸

Philadelphia, Pennsylvania, United States

Scripps Cancer Center

🇺🇸

La Jolla, California, United States

Comprehensive Cancer Centers of the Desert

🇺🇸

Palm Springs, California, United States

University of Rochester Cancer Center

🇺🇸

Rochester, New York, United States

Oncology Associates

🇺🇸

Cedar Rapids, Iowa, United States

VA Connecticut Healthcare System

🇺🇸

West Haven, Connecticut, United States

SMDC Health Systems

🇺🇸

Duluth, Minnesota, United States

Hematology Oncology Consultants Inc

🇺🇸

St. Louis, Missouri, United States

Hematology Oncology Associates of NJ

🇺🇸

Paramus, New Jersey, United States

Yakima Regional CancerCenter

🇺🇸

Yakima, Washington, United States

Florida Cancer Specialists

🇺🇸

Fort Myers, Florida, United States

Desert Hematology Oncology Medical Group INC

🇺🇸

Rancho Mirage, California, United States

Whittingham Cancer Center

🇺🇸

Norwalk, Connecticut, United States

Jackson Oncology Associates PLLC

🇺🇸

Jackson, Mississippi, United States

Southern Nevada Cancer Research Foundation

🇺🇸

Las Vegas, Nevada, United States

Summit Medical Group/Overlook Oncology Center

🇺🇸

Summit, New Jersey, United States

VAMC Northport

🇺🇸

Northport, New York, United States

Memorial Sloan Kettering Cancer Ctr

🇺🇸

New York, New York, United States

Northwestern Carolina Hematology Oncology PA

🇺🇸

Hickory, North Carolina, United States

Staten Island Unversity Hospital

🇺🇸

Staten Island, New York, United States

Medical Oncology Associates

🇺🇸

Kingston, Pennsylvania, United States

Wake Forest Univ School of Medicine

🇺🇸

Winston Salem, North Carolina, United States

Oncology/Hematology Care Inc

🇺🇸

Cincinnati, Ohio, United States

Lancaster Cancer Center LTD

🇺🇸

Lancaster, Pennsylvania, United States

Central Utah Medical Clinic

🇺🇸

Provo, Utah, United States

Western Pennsylvania Cancer Institute

🇺🇸

Pittsburgh, Pennsylvania, United States

Swedish Cancer Institute

🇺🇸

Seattle, Washington, United States

Oregon Health & Science University

🇺🇸

Portland, Oregon, United States

Southeast Florida Hematology-Oncology

🇺🇸

Ft. Lauderdale, Florida, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

InterMountain Hematology/Oncology

🇺🇸

Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath